scorecardresearch
Sunday, July 27, 2025
TopicDr Reddy's

Topic: Dr Reddy's

Govt’s Covid expert panel rejects Dr Reddy’s proposal to lift restrictions on Remdesivir use

Dr. Reddy’s sought a change in regulatory approval status for Remdesivir injection from 'restricted emergency use' to 'full marketing authorisation'.

Dr Reddy’s hit by cyberattack days after India approves trial of Russia’s Covid vaccine

Dr Reddy's said it had shut down plants and isolated data centres after cyber attack, but expects all services to be back up in 24 hours.

Dr Reddy’s gets drug controller’s nod to conduct human clinical trial for Russian vaccine

Earlier in September 2020, Dr.Reddy's and Russian Direct Investment Fund entered into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.

Dr Reddy’s potential cancer drug shows promise against Covid, gets nod for phase 3 trial

The drug was tested on 40 patients during phase 2 trials. But, the govt’s expert panel found the sample size ‘inadequate’ to approve the drug for marketing in India.

Govt panel rejects Dr Reddy’s proposal to test Russian vaccine Sputnik V in Phase III trial

Dr Reddy’s had proposed to test Sputnik V in a Phase III clinical trial that generally needs to enroll over 1,000 participants. Govt panel has recommended a smaller trial instead.

Russia ties up with Dr Reddy’s for phase 3 clinical trials of Covid hope Sputnik V in India

RDIF will supply 100 million doses of Sputnik V — the Covid vaccine developed by Russian researchers — in India once it has received all the regulatory clearances.

Dr Reddy’s signs deal with Gilead to register, manufacture and sell Remdesivir in India

The non-exclusive licensing agreement covers 127 countries, including India. Remdesivir is currently approved in the US for the emergency Covid treatment.

Govt asks pharma firms when remdesivir, the big hope against Covid, can be made in India

Drug has shown benefits in reducing recovery time for some patients, and the govt has asked companies if they’re in touch with Gilead Sciences for a licence.

In a first, India’s Dr Reddy’s Labs to supply a generic drug to China’s public hospitals

Amid concerns about rising trade deficit between India and China, Dr Reddy’s has won a tender to supply Olanzapine, a drug used to treat mental ailments.

On Camera

Maharashtra’s language war reaches West Bengal. Actor Prosenjit Chatterjee is the first victim

While the language war in other states is targeting those who can't speak the local language, in Bengal, even those whose mother tongue is Bengali have to constantly prove their Bengali-ness.

India-US set to ink mini trade deal soon, reach understanding on agricultural & dairy products

Mini deal will likely see no cut in 10% baseline tariff on Indian exports announced by Trump on 2 April, it is learnt, but additional 26% tariffs are set to be reduced.

DRDO successfully tests latest version of UAV-launched precision missile, ULPGM-V3

Capable of being fired in plain and high-altitude areas, it has day-and-night capability and two-way data link to support post-launch target, aim-point update.

Modi’s Bharat vs Indira’s India: 11-yr report card of politics, diplomacy, economy, nationalism

As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.